Women Who Test Negative for HPV Can Safely Screen Every Five Years, Study Shows
A new study supports the extension of cervical cancer screening intervals to five years for those with a negative screen result.
Category: Cervical (HPV)
Cervical (HPV)
Latest
Cervical (HPV)
Latest
Cervical Cancer Screening Has Kept Rates Stable or in Decline
A recent trend analysis indicates that cervical cancer and mortality rates have remained stable or are dropping, in part, because of screening
Cervical (HPV)
Latest
Hologic, Google Cloud Collaborating on Digital Diagnostics for Cervical Cancer
The Hologic Genius Digital Diagnostics System is expected to derive even more actionable insights from cytology slides for cytotechnologists and pathologists with Google Cloud.
Multicancer Blood Test, Combined with Imaging, Shows Promise as Screen for Cancer
The blood test followed by PET-CT imaging was 99.6% specific for cancer.
Read More
FDA Approves Roche’s Cobas HPV Test to Identify Cervical Cancer Risk
The test identifies women at risk for cervical cancer by detecting the presence of high-risk human papillomavirus DNA in cervical samples.
Read More
Interventional Study to Evaluate Multicancer Early Detection Test
The Pathfinder study will enroll 6,200 participants to evaluate Grail’s investigational multicancer early detection test in clinical practice.
Read More
Study Offers Promise for Multicancer Detection from a Single Blood Draw
Bluestar Genomics’ technology can noninvasively detect cancers and help identify the underlying biology of the disease using epigenetic markers.
Read More
FDA Approves Roche’s CINtec Plus Cytology Test to Aid Cervical Cancer Prevention
CINtec Plus cytology is the first biomarker-based triage test for women whose primary cervical cancer screening results are positive for the human papillomavirus using the Cobas 4800 HPV test.
Read More
New Diagnostic Test for High-Risk Strains of HPV
The new human papillomavirus assay is a real-time polymerase chain reaction-based test that detects 15 recognized high-risk genotypes of HPV DNA.
Read More
Reducing Cervical Cancer
Some argue that cytology adds little to cervical screening efforts, prompting additional discussion on the contribution of cytology to screening protocols.
Read More
Screening Effectively Decreases Rare Cases of Cervical Cancer
Women who participated in the screening program were less likely to develop adenosquamous and other rare types of cervical cancer.
Read More
Global Cloud-Based Cervical Cancer Screening Platform Launched
Wuhan University has joined with the Landing Med enterprise to create an international platform for Cloud-based cervical cancer screening.
Read More
Qiagen’s CareHPV Test Earns WHO Prequalification Status for Cervical Cancer Screening
WHO prequalification recognizes the important role that the CareHPV test can have in screening women in emerging countries for HPV.
Read More
Cobas HPV Test Earns FDA Nod for Use with SurePath Preservative Fluid
The Roche test is approved for first-line screening with both SurePath preservative fluid and ThinPrep PreservCyt, the two most common collection media for Pap tests.
Read More
USPSTF Recommends Multiple Options for Screening Women for Cervical Cancer
Women aged 21 to 65 benefit from screening, and the USPSTF recommends three strategies for screening women aged 30 to 65.
Read More
From the Editor: USPSTF Broadens HPV Testing Guidelines
Guidelines on diagnostic testing issued by the United States Preventive Services Task Force...
Read MoreFast Track Diagnostics Releases PCR Kit for the Detection of 14 HPV High-Risk Subtypes
Fast Track Diagnostics has expanded its comprehensive sexually transmitted infections portfolio by adding an array of human papillomavirus (HPV) tests.
Read More
Study Reveals Large Disparities in Survival for Patients with HPV-Associated Cancers
A recent study has found large disparities in survival by sex, race, and age, among patients diagnosed with cancers caused by the human papillomavirus.
Read More